Prognostic utility of a glycoprotein tumor-associated antigen (TA90) specific immune complex assay in patients with cancer
Clinical and Applied Immunology Reviews · 2004
DOI: 10.1016/j.cair.2004.06.001 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Applied Immunology Reviews, 2004. Verfasst von Rishab K. Gupta und 1 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 60 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Gupta, R. K., & Morton, D. L. (2004). Prognostic utility of a glycoprotein tumor-associated antigen (TA90) specific immune complex assay in patients with cancer. Clinical and Applied Immunology Reviews. https://doi.org/10.1016/j.cair.2004.06.001
Vancouver
Gupta RK, Morton DL. Prognostic utility of a glycoprotein tumor-associated antigen (TA90) specific immune complex assay in patients with cancer. Clinical and Applied Immunology Reviews. 2004. doi:10.1016/j.cair.2004.06.001
BibTeX
@article{Gupta2004,
author = {Gupta, Rishab K. and Morton, Donald L.},
title = {Prognostic utility of a glycoprotein tumor-associated antigen (TA90) specific immune complex assay in patients with cancer},
journal = {Clinical and Applied Immunology Reviews},
year = {2004},
doi = {10.1016/j.cair.2004.06.001}
}
EUVIMED